CA2419223A1 - Use of perfluoroalkyl-containing metal complexes as contrast media in mr-imaging for visualization of plaques, tumours and necroses - Google Patents

Use of perfluoroalkyl-containing metal complexes as contrast media in mr-imaging for visualization of plaques, tumours and necroses Download PDF

Info

Publication number
CA2419223A1
CA2419223A1 CA002419223A CA2419223A CA2419223A1 CA 2419223 A1 CA2419223 A1 CA 2419223A1 CA 002419223 A CA002419223 A CA 002419223A CA 2419223 A CA2419223 A CA 2419223A CA 2419223 A1 CA2419223 A1 CA 2419223A1
Authority
CA
Canada
Prior art keywords
beta
alpha
groups
general formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002419223A
Other languages
English (en)
French (fr)
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduchel
Hanns-Joachim Weinmann
Bernd Misselwitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10040380A external-priority patent/DE10040380B4/de
Application filed by Individual filed Critical Individual
Publication of CA2419223A1 publication Critical patent/CA2419223A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002419223A 2000-08-11 2001-07-23 Use of perfluoroalkyl-containing metal complexes as contrast media in mr-imaging for visualization of plaques, tumours and necroses Abandoned CA2419223A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040380A DE10040380B4 (de) 2000-08-11 2000-08-11 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10040380.8 2000-08-11
PCT/EP2001/008498 WO2002013874A2 (de) 2000-08-11 2001-07-23 Verwendung von perfluoralkylhaltigen metallkomplexen als kontrastmittel im mr-imaging zur darstellung von plaques, tumoren und nekrosen

Publications (1)

Publication Number Publication Date
CA2419223A1 true CA2419223A1 (en) 2003-02-11

Family

ID=7652860

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002419223A Abandoned CA2419223A1 (en) 2000-08-11 2001-07-23 Use of perfluoroalkyl-containing metal complexes as contrast media in mr-imaging for visualization of plaques, tumours and necroses

Country Status (26)

Country Link
EP (1) EP1307236A2 (de)
JP (1) JP2004506025A (de)
KR (1) KR20030022387A (de)
CN (1) CN1469757A (de)
AR (1) AR034139A1 (de)
AU (2) AU2001277549B2 (de)
BG (1) BG107542A (de)
BR (1) BR0113188A (de)
CA (1) CA2419223A1 (de)
CZ (1) CZ2003392A3 (de)
DE (1) DE10066210B4 (de)
EE (1) EE200300061A (de)
HR (1) HRP20030173A2 (de)
HU (1) HUP0300736A3 (de)
IL (1) IL154385A0 (de)
MX (1) MXPA03001287A (de)
NO (1) NO20030604L (de)
NZ (1) NZ523932A (de)
PL (1) PL365596A1 (de)
RU (1) RU2290206C2 (de)
SK (1) SK1572003A3 (de)
TW (1) TWI296931B (de)
UA (1) UA82642C2 (de)
WO (1) WO2002013874A2 (de)
YU (1) YU10603A (de)
ZA (1) ZA200301949B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263040B2 (en) 2006-10-18 2012-09-11 Bayer Schering Pharma Ag Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use
US11104639B2 (en) 2016-09-14 2021-08-31 Daikin Industries, Ltd. Branched fluorine-containing compound

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
DE102005008309A1 (de) * 2005-02-17 2006-08-24 Schering Ag Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
US7887835B2 (en) * 2006-09-19 2011-02-15 Fujifilm Corporation Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
JP2011190183A (ja) * 2010-03-11 2011-09-29 Noguchi Institute フルオラス化糖結合型クラウンエーテル誘導体
US9976072B2 (en) 2014-03-26 2018-05-22 Chevron U.S.A. Inc. Multicarboxylate compositions and method of making the same
EP3101012A1 (de) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Neue gadoliniumchelat-verbindung zur verwendung in der magnetresonanzbildgebung
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CA3120665A1 (en) 2018-11-23 2020-05-28 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
CN109867635A (zh) * 2019-02-14 2019-06-11 华东师范大学 一种t1型胶束磁共振成像造影剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
JPH10112939A (ja) * 1996-10-07 1998-04-28 Nec Corp 電源切替回路
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263040B2 (en) 2006-10-18 2012-09-11 Bayer Schering Pharma Ag Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use
US11104639B2 (en) 2016-09-14 2021-08-31 Daikin Industries, Ltd. Branched fluorine-containing compound
US11680037B2 (en) 2016-09-14 2023-06-20 Daikin Industries, Ltd. Branched fluorine-containing compound

Also Published As

Publication number Publication date
AU7754901A (en) 2002-02-25
ZA200301949B (en) 2004-12-14
BR0113188A (pt) 2003-06-24
EE200300061A (et) 2004-12-15
WO2002013874A8 (de) 2002-06-13
SK1572003A3 (en) 2003-10-07
YU10603A (sh) 2006-05-25
HUP0300736A3 (en) 2010-01-28
EP1307236A2 (de) 2003-05-07
IL154385A0 (en) 2003-09-17
WO2002013874A2 (de) 2002-02-21
JP2004506025A (ja) 2004-02-26
NZ523932A (en) 2007-07-27
MXPA03001287A (es) 2003-10-06
BG107542A (bg) 2003-09-30
NO20030604D0 (no) 2003-02-07
CN1469757A (zh) 2004-01-21
UA82642C2 (uk) 2008-05-12
RU2290206C2 (ru) 2006-12-27
DE10066210B4 (de) 2008-02-28
HRP20030173A2 (en) 2005-04-30
AU2001277549B2 (en) 2007-02-08
TWI296931B (en) 2008-05-21
KR20030022387A (ko) 2003-03-15
AR034139A1 (es) 2004-02-04
NO20030604L (no) 2003-04-11
CZ2003392A3 (cs) 2003-09-17
HUP0300736A2 (hu) 2003-09-29
PL365596A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
CA2419223A1 (en) Use of perfluoroalkyl-containing metal complexes as contrast media in mr-imaging for visualization of plaques, tumours and necroses
JP4163381B2 (ja) 生理学的薬剤の検出のための磁気共鳴造影剤
US6818203B2 (en) Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
CA2194560A1 (en) Cascade-polymer complexes and methods of producing the same
AU2001289729B2 (en) Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
CA2304458A1 (en) Contrasting agent for infarct and necrosis imaging
AU2006272025A1 (en) Complexes containing perfluoroalkyl, method for the production and use thereof
CA2362703A1 (en) Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
US6641797B2 (en) Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
ZA200301947B (en) Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof.
US6113880A (en) Polyrotaxane derivatives for x-ray and nuclear magnetic resonance imaging
JP5475454B2 (ja) 過弗素化されたｐｅｇ基を有する金属キレート類、それらの製剤方法、及びそれらの使用
US6676928B2 (en) Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
CA2491933A1 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in magnetic resonance imaging for representing intravascular thrombi
DE10040380A1 (de) Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques, Tumoren und Nekrosen
KR20050017095A (ko) 혈관내 혈전을 나타내기 위한 자기 공명 영상화에서의조영제로서 퍼플루오로알킬 함유 금속 착물의 용도

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued